Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Videos
Hematology
12th March 2024
EAHAD 2024 – Interview with the Congress President
EMJ sat down with EAHAD President, Wolfgang Miesbach, live at this year’s congress in Frankfurt, Germany. Miesbach highlighted key…
Hematology
28th February 2024
EAHAD 2024 - Key Reflections from the Congress President
Live from EAHAD 2024, Wolfgang Miesbach, Congress President, shares a glimpse of the event, emphasises stand-out sessions from the…
Neurology
18th January 2024
ECTRIMS 2023 Symposium: The Latest Developments in MS Classification and Treatment: From AI to Clinical Decision Making
The Latest Developments in MS Classification and Treatment: From AI to Clinical Decision Making, a BMS-promotional Symposium ECTRIMS 2023, presents a thought-provoking view on the latest developments in the field of Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. IMM-GB-2300537 | Date of Prep: Jan 2024
Hepatology
12th January 2024
Adult-Onset Progressive Familial Intrahepatic Cholestasis: Case Study
This video is a short clip extracted from the integrated symposium at the 58th Annual Meeting of the European Association for the Study of…
Oncology
20th December 2023
Working Together to Tackle Cancer
Find out how Daiichi Sankyo scientists are uncovering new ways to address needs in cancer.
Dermatology
13th December 2023
Dermatology Meets Obstetrics: A Psoriasis Step Forward Together with UCB
UCB hosted an industry expert hub session entitled ‘Dermatology and Obstetrics: How Can Teamwork Lead to Compatible Treatment Choices…
Dermatology
13th December 2023
The Dawn of a New Era in Vitiligo Management
This video explores, understanding vitiligo as an autoimmune skin disease, integrating ruxolitinib cream into vitiligo treatment strategy, and the importance of real-world evidence in reinforcing findings from clinical trials.
Rheumatology
8th December 2023
BIMZELX®▼ (bimekizumab) Mode of Action
Learn about the mechanism of action for Bimzelx (bimekizumab). To find out more, please visit www.bimzelx.eu…
Loading posts...
« Previous
1
…
3
4
5
6
7
…
82
Next »